🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07490457
Starting soon Not applicable

Intraoperative Ketamine for Chronic Postoperative Pain After Open-Heart Surgery

NCT07490457 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-15
Last updated
2026-03-24

Condition(s) studied

Cardiac AnaesthesiaChronic PainPost Operative Pain, ChronicPost Operative Pain, AcuteKetaminePain

Investigational drug(s) / intervention(s)

Ketamine groupControl Group

Ketamine group: Ketamine group: Single IV bolus of ketamine 1 mg/kg administered after induction of anesthesia and prior to skin incision

Control Group: Control group: Single IV bolus of normal saline (placebo) labeled as study drug administered after induction of anesthesia and prior to skin incision.

Study summary

The goal of this interventional study is to determine whether a single intraoperative IV dose of ketamine can reduce postoperative chronic and acute pain and postoperative opioid requirements in adult patients undergoing open-heart surgery under general anesthesia. The main questions it aims to answer are:

Primary outcome: Does a single-dose intraoperative IV ketamine reduce the presence and severity of pain at 3 and 6 months after surgery ? Secondary outcomes: Does it reduce acute postoperative pain scores, opioid consumption, and other recovery-related outcomes in the early postoperative period ? Researchers will compare a single-dose IV ketamine arm to a placebo arm to see if ketamine decreases chronic pain incidence at 3 and 6 months and improves acute pain/opioid-related outcomes.

Participants will:

Be randomized to receive either a single IV bolus of ketamine or placebo during surgery.

Undergo standard general anesthesia and open cardiac surgery per protocol. Have postoperative pain assessed using Numeric Rating Scale (NRS) at extubation, 0, 3, 6, 12, 24, and 48 hours.

Have opioid and additional analgesic use recorded, time to first rescue analgesic noted, and ICU/hospital length of stay tracked.

Be evaluated for ICU delirium (CAM-ICU) and complete Quality of Recovery-15, Brief Pain Inventory-Short Form, and Pain Self-Efficacy questionnaires.

Be followed up at 3 and 6 months for assessment of chronic postoperative pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * ASA II-III, * Patients scheduled for elective on-pump open cardiac surgery via median sternotomy. Exclusion Criteria: * Emergency surgery requirement * Need for reoperation * Requirement for postoperative re-intubation * History of opioid use * Preoperative diabetic neuropathy or autonomic dysfunction * Hepatic or renal dysfunction * History of neuropathic pain * Neurocognitive disorders such as psychosis or dementia * Use of antidepressants or antipsychotics * Body mass index (BMI) \> 40

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bursa City Hospital, Bursa nilüfer

More Bursa City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07490457 on ClinicalTrials.gov ↗ ← All trials in Turkey